RNA-guided nucleases and active fragments and variants thereof and methods of use

WO2025083619A9PCT designated stage expired Publication Date: 2026-06-04LIFEEDIT THERAPEUTICS INC

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
LIFEEDIT THERAPEUTICS INC
Filing Date
2024-10-17
Publication Date
2026-06-04

Smart Images

  • Figure IB2024060233_04062026_PF_FP_ABST
    Figure IB2024060233_04062026_PF_FP_ABST
Patent Text Reader

Abstract

Compositions and methods for binding to a target sequence of interest are provided. The compositions find use in cleaving or modifying a target sequence of interest, visualization of a target sequence of interest, and modifying the expression of a sequence of interest. Compositions comprise RNA-guided nuclease (RGN) polypeptides, CRISPR RNAs, guide RNAs, and nucleic acid molecules encoding the same. Vectors and host cells comprising the nucleic acid molecules are also provided. Further provided are RGN systems for binding a target sequence of interest, wherein the RGN system comprises an RNA-guided nuclease polypeptide and one or more guide RNAs.
Need to check novelty before this filing date? Find Prior Art